Edaravone and carnosic acid synergistically enhance the expression of nerve growth factor in human astrocytes under hypoxia/reoxygenation

Neuroscience Research

Volumn 69, Issue 4, 2011, Pages 291-298

  Yoshida, Hidemi ^a   Mimura, Junsei ^a   Imaizumi, Tadaatsu ^a   Matsumiya, Tomoh ^a   Ishikawa, Akira ^b   Metoki, Norifumi ^c   Tanji, Kunikazu ^a   Ota, Ken ^a   Hayakari, Ryo ^a   Kosaka, Kunio ^d   Itoh, Ken ^a   Satoh, Kei ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c Hirosaki Stroke Center   (Japan)

^d Osaka City University Medical School   (Japan)

Author keywords

Carnosic acid; Edaravone; Ischemia; NGF; Nrf2; Reperfusion

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CARNOSIC ACID; NERVE GROWTH FACTOR; NORPHENAZONE; PROTEIN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR NRF2;

ARTICLE; ASTROCYTE; CONTROLLED STUDY; CULTURE TECHNIQUE; DRUG POTENTIATION; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REOXYGENATION;

ANTIOXIDANTS; ANTIPYRINE; ASTROCYTES; CELL SURVIVAL; CELLS, CULTURED; DITERPENES, ABIETANE; DRUG SYNERGISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; IMMUNOBLOTTING; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NERVE GROWTH FACTOR; PLANT EXTRACTS; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 79951956146     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2010.12.016     Document Type: Article

References (41)

1. Aloe A., Alleva E., Fiore M. Stress and nerve growth factor. Finding in animal models and humans. Pharmacol. Biochem. Behav. 2002, 73:159-166.
2. Brown A., Ricci M.J., Weaver L.C. NGF message and protein distribution in the injured rat spinal cord. Exp. Neurol. 2004, 188:115-127.
3. Chen P.C., Vargas M.R., Pani A.K., Smeyne R.J., Johnson D.A., Kan Y.W., Johnson J.A. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role of astrocytes. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:2933-2938.
4. Cheng B., Mattson M.P. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 1991, 7:1031-1041.
5. Davis T., Bachler M.A., Wyllie F.S., Bagley M.C., Kipling D. Evaluating the role of p38 MAP kinase in growth of Werner syndrome fibroblasts. Ann. N. Y. Acad. Sci. 2010, 1197:45-48.
6. Hacke W., Kaste M., Bluhmki E., Brozman M., Dávalos A., Guidetti D., Larrue V., Lees K.R., Medeghri Z., Machnig T., Schneider D., von Kummer R., Wahlgren N., Toni D. Thrombolysis with alteplase 3 to 4.5hours after acute ischemic stroke. N. Engl. J. Med. 2008, 359:1317-1329. ECASS Investigators.
7. Higashi Y. Edaravone for the treatment of acute cerebral infarction: role of endothelium-derived nitric oxide and oxidative stress. Expert Opin. Pharmacother. 2009, 10:323-331.
8. Hosoya T., Maruyama A., Kang M.I., Kawatani Y., Shibata T., Uchida K., Uchida K., Warabi E., Noguchi N., Itoh K., Yamamoto M. Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. J. Biol. Chem. 2005, 280:27244-27250.
9. Ishikawa A., Yoshida H., Metoki N., Toki T., Imaizumi T., Matsumiya T., Yamashita K., Taima K., Satoh K. Edaravone inhibits the expression of vascular endothelial growth factor in human astrocytes exposed to hypoxia. Neurosci. Res. 2007, 59:406-412.
10. Itoh K., Wakabayashi N., Katoh Y., Ishii T., Igarashi K., Engle J.D., Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999, 13:76-86.
11. Johnson J.A., Johnson D.A., Kraft A.D., Calkins M.J., Jakel R.J., Vargas M.R., Chen P.C. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann. N. Y. Acad. Sci. 2008, 1147:61-69.
12. Jellinger K.A. Recent advances in our understanding of neurodegeneration. J. Neural Transm. 2009, 116:1111-1162.
13. Kitagawa Y. Edaravone in acute ischemic stroke. Intern. Med. 2006, 45:225-226.
14. Knott A.B., Perkins G., Schwarzenbacher R., Bossy-Wetzel E. Mitochondrial fragmentation in neurodegeneration. Nat. Rev. Neurosci. 2008, 9:505-518.
15. Kobayashi A., Kang M.I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., Igarashi K., Yamamoto M. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 2004, 24:7130-7139.
16. Kosaka K., Yokoi T. Carnosic acid, a component of rosemary (Rosmarinus officinalis L.), promotes synthesis of nerve growth factor in T98G human glioblastoma cells. Biol. Pharm. Bull. 2003, 26:1620-1622.
17. Lee T.-H., Kato H., Chen S.-T., Kogure K., Itoyama Y. Expression of nerve growth factor and trkA after transient focal cerebral ischemia in rats. Stroke 1998, 29:1687-1697.
18. Lees K.R. Stroke: success for extending acute treatment. Lancet Neurol. 2009, 8:2-4.
19. Lyskissas M.G., Batistatou A.K., Charalabopoulos K.A., Beris A. The role of neurotrophins in axonal growth, guidance, and regeneration. Curr. Neurovasc. Res. 2007, 4:143-151.
20. Matsumiya T., Imaizumi T., Yoshida H., Satoh K., Topham M.K., Stafforini D.M. The levels of retinoic acid-inducible gene I are regulated by heat shock protein 90-α. J. Immunol. 2009, 182:2717-2725.
21. Motohashi H., Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 2004, 10:549-557.
22. Nilsoli E., Tonello C., Benarese M., Liberini P., Carruba M.O. Expression of nerve growth factor in brown adipose tissue: implication for thermogenesis and obesity. Endocrinology 1996, 137:495-503.
23. Oderfeld-Nowak B., Bacia A. Expression of astroglial nerve growth factor in damaged brain. Acta Neurobiol. Exp. (Wars.) 1994, 54:73-80.
24. Otten U., März P., Heese K., Hoch C., Kunz D., Rose-John S. Cytokines and neurotrophins interact in normal and diseased states. Ann. N. Y. Acad. Sci. 2000, 917:322-330.
25. Satoh T., Izumi M., Inukai Y., Tsutsumi Y., Nakayama N., Kosaka K., Shimojo Y., Kitajima C., Itoh K., Yokoi T., Shirasawa T. Carnosic acid protects neuronal HT22 cells through activation of the antioxidant-responsive element in free carboxylic acid- and catechol hydroxyl moieties-dependent manners. Neurosci. Lett. 2008, 434:260-265.
26. Satoh T., Kosaka K., Itoh K., Kobayashi A., Yamamoto M., Shimojo Y., Kitajima C., Cui J., Kamins J., Okamoto S., Izumi M., Shirasawa T., Lipton S.A. Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J. Neurochem. 2008, 104:1116-1131.
27. Seip W.F., Evans G.L. Atmospheric analysis and redox potentials of cultured media in the GasPak system. J. Clin. Microbiol. 1980, 11:226-233.
28. Shibata H., Arai S., Izawa M., Murasaki M., Takamatsu Y., Izawa O., Takahashi C., Tanaka M. Phase I clinical study of MCI-186 (edaravone, 3-methyl-1-phenyl-2-pyrazolin-5-one) in healthy volunteers: safety and pharmacokinetics of single and multiple administrations. Jpn. J. Clin. Pharmacol. Ther. 1998, 29:863-876. (in Japanese with English abstract).
29. Takahashi T., Tabuchi T., Tamaki Y., Kosaka K., Takikawa Y., Satoh T. Carnosic acid and carnosol inhibit adipocyte differentiation in mouse 3T3-L1 cells through induction of phase2 enzymes and activation of glutathione metabolism. Biochem. Biophys. Res. Commun. 2009, 382:549-554.
30. Toyoda K., Fujii K., Kamouchi M., Nakane H., Arihiro S., Okada Y., Ibayashi S., Iida M. Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion. J. Neurol. Sci. 2004, 221:11-17.
31. Villoslada P., Genain C.P. Role of nerve growth factor and other trophic factors in brain inflammation. Prog. Brain Res. 2004, 146:403-414.
32. Wahlgren N., Ahmed N., Dávalos A., Hacke W., Millán M., Muir K., Roine R.O., Toni D., Lee K.R. Thrombolysis with alteplase 3 to 4.5hours after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008, 372:1303-1309. SITS investigators.
33. Watanabe K., Morinaka Y., Iseki K., Watanabe T., Yuki S., Nishi H. Structure-activity relationship of 3-methyl-1-phenyl-2-pyrazolin-5-one (edaravone). Redox Rep. 2003, 8:151-155.
34. Watanabe T., Yuki S., Egawa M., Nishi H. Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J. Pharmacol. Exp. Ther. 1994, 268:1597-1604.
35. Watanabe T., Yuki S., Saito K., Sato S., Sugimoto J., Ohori Y. Pharmacological studies of MCI-186, a new drug for acute stroke. Jpn. Pharmacol. Ther. 1997, 25:S-1691-S-1698. (in Japanese with English abstract, figures and tables).
36. Yokota S., Kumagai Y., Uchiumi M., Isawa S., Murasaki M., Akimoto K., Iwamoto M., Yuasa T., Iwano M. A pharmacokinetic study of MCI-186, a novel drug for cerebrovascular disease in elderly and young healthy subjects. Jpn. J. Clin. Pharmacol. Ther. 1997, 28:693-702. (in Japanese with English abstract).
37. Yoshida H., Imaizumi T., Lee S.J., Tanji K., Sakaki H., Matsumiya T., Ishikawa A., Taima K., Yuzawa E., Mori F., Wakabayashi K., Kimura H., Satoh K. Retinoic acid-inducible gene-I mediates RANTES/CCL5 expression in U373MG human astrocytoma cells stimulated with double-stranded RNA. Neurosci. Res. 2007, 58:199-206.
38. Yoshida H., Imaizumi T., Tanji K., Sakaki H., Metoki N., Hatakeyama M., Yamashita K., Ishikawa A., Taima K., Sato Y., Kimura H., Satoh K. Platelet-activating factor enhances the expression of nerve growth factor in normal human astrocytes under hypoxia. Mol. Brain Res. 2005, 133:95-101.
39. Yoshida H., Metoki N., Ishikawa A., Imaizumi T., Matsumiya T., Tanji K., Ota K., Ohyama C., Satoh K. Edaravone improves the expression of nerve growth factor in human astrocytes subjected to hypoxia/reoxygenation. Neurosci. Res. 2010, 66:284-289.
40. Yoshida H., Yanai H., Namiki Y., Fukatu-Sasaki K., Furutani N., Tada N. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev. 2006, 12:9-20.
41. Zhang Y., Tatsuno T., Carney J.M., Mattson M.P. Basic FGF, NGF, and IGFs protect hippocampal and cortical neurons against iron-induced degeneration. J. Cereb. Blood Flow Metab. 1993, 13:378-388.